We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Life Technologies Buys Instruments Distributor in Korea

By LabMedica International staff writers
Posted on 17 Jun 2013
Print article
Life Technologies Corp. (Carlsbad, CA, USA) announced the acquisition of an instrument distributor Life Science Korea (LSK; Seoul, Republic of Korea).

LSK has been Life Technologies’' primary instrument distributor since 1994 and holds distribution rights to Applied Biosystems products, including next-generation sequencing instruments, Sanger sequencing systems, forensics, and polymerase chain reaction (PCR) products. LSK serves more than 1,000 customers in academia, government, pharmaceutical, biotech, hospitals, and applied markets. Under the acquisition terms, the LSK name will become part of Life Technologies Korea. No other terms of the deal were announced.

The combination of LSK and Life Technologies will continue to build a strong Life Technologies brand in Korea to stimulate fast and sustainable growth and be well positioned to take advantage of Korea’s focus on developing biotechnology. In the past five years, South Korea has shown solid growth in the biotechnology industry and with the Korean government's Bio-vision 2016 initiative, it is expected that the country will continue to invest heavily in the life sciences industry.

Life Technologies is a global biotechnology company with portfolio of 50,000 end-to-end solutions secured by more than 5,000 patents and licenses that span the following biologic spectrum-scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine, and agricultural research.

“The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our current capabilities and platforms in this important market,” said Mark Smedley, president of Life Technologies, Asia Pacific, Japan region. “The combination of Life Technologies Korea and LSK, bolstered by our recent acquisition of consumables distributor KDR, enables us to offer one channel to serve the many different needs of our South Korean customers and to create a superior purchasing experience.”

Related Links:
Life Technologies
Life Science Korea


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.